Reference
Vari D, et al. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiology in the Young 31: 63-70, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1017/S1047951120003297
Rights and permissions
About this article
Cite this article
Alprostadil. Reactions Weekly 1869, 24 (2021). https://doi.org/10.1007/s40278-021-00889-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-00889-y